Epidemiological investigations have demonstrated that low serum levels of the vitamin D metabolite 25(OH)D, the precursor molecule for the hormone 1,25(OH)2D, are associated with risk of colorectal neoplasia, though results have been equivocal, and little is known about sex- or colorectal sub-site-specific relationships for these biomarkers. From a functional standpoint, anti-proliferative, pro-differentiating, and growth inhibitory effects of 1,25(OH)2D have been shown in colorectal cancer cell lines. Thus, there is compelling evidence that active vitamin D metabolites play a role in reducing the risk for colorectal neoplasia, but the best approach for attaining optimal levels of 1,25(OH)2D at the cellular level are not known, and the functional effects of genetic variation in the vitamin D receptor (VDR) or in primary enzymes responsible for metabolism of 1,25(OH)2Dat the tissue level are poorly understood. Preliminary evidence indicates that SNPs in VDR may influence circulating concentrations of 1,25(OH)2D;further, two enzymes, CYP27B1 and CYP24A1, are of particular importance in metabolic homeostasis of this molecule. Although there has been research into the functionality of and epidemiological associations of the VDR, there are few studies of the molecular or epidemiological effects of genetic variation in these two key enzymes. Further, the mechanisms through which vitamin D may exert its chemopreventive effects are unknown, though work by our group as well as others suggests that APC, b-catenin, and 1,25(OH)2D-VDR represent a molecular "crossroads" of intracellular regulators of colonic cell proliferation.
The specific aims of the proposed work are to 1) Measure circulating 25(OH)D and 1,25(OH)2D concentrations among participants in clinical trials of colorectal adenoma recurrence, and assess the association between these variables and the odds of adenoma recurrence;2) Genotype study participants for variation in VDR, CYP27B1 and CYP24A1 and evaluate the association between SNPs and odds for colorectal adenoma recurrence and circulating concentrations of vitamin D metabolites;3) Elucidate the functional effects of selected polymorphisms in the CYP27B1 and CYP24A1 genes in human Caco-2 colonic cells;4) Investigate molecular crosstalk between VDR (and VDR polymorphic variants) and 2-catenin, as well as the functional influence of APC on these signal transduction pathways. Secondary aims include investigation of sex-stratified associations between vitamin D metabolites and recurrence of adenomas and advanced adenomas, as well as assessment of whether these associations vary by colorectal sub-site. This work has the potential to offer a cost-effective preventative measure for colorectal carcinogenesis through improving vitamin D status, as well as to illuminate novel molecular evidence for the functional effects of genetic variation in key enzymes of vitamin D metabolism, and for the elucidation of signaling pathways, including APC and b-catenin, that likely modulate the actions of vitamin D metabolites and VDR.

Public Health Relevance

The proposed work has the potential to offer a cost-effective preventative measure for colorectal carcinogenesis through improving vitamin D status, as well as providing molecular evidence for the functional effects of genetic variation in key enzymes in the vitamin D pathway, and for the pathways through which vitamin D metabolites are acting, including via APC/B-catenin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA140285-05
Application #
8607147
Study Section
Epidemiology of Cancer Study Section (EPIC)
Program Officer
Riscuta, Gabriela
Project Start
2010-03-01
Project End
2015-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
5
Fiscal Year
2014
Total Cost
$272,962
Indirect Cost
$49,403
Name
University of Arizona
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Hibler, Elizabeth A; Jacobs, Elizabeth T; Stone, Angelika Dampf et al. (2014) Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer Prev Res (Phila) 7:426-34
Hsieh, Jui-Cheng; Estess, Rudolf C; Kaneko, Ichiro et al. (2014) Vitamin D receptor-mediated control of Soggy, Wise, and Hairless gene expression in keratinocytes. J Endocrinol 220:165-78
Hibler, Elizabeth A; Molmenti, Christine L Sardo; Lance, Peter et al. (2014) Associations between circulating 1,25(OH)?D concentration and odds of metachronous colorectal adenoma. Cancer Causes Control 25:809-17
Austin, Heather R; Hoss, Elika; Batie, Shane F et al. (2014) Regulation of late cornified envelope genes relevant to psoriasis risk by plant-derived cyanidin. Biochem Biophys Res Commun 443:1275-9
Jacobs, Elizabeth T; Hibler, Elizabeth A; Lance, Peter et al. (2013) Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer 133:2980-8
Jacobs, Elizabeth T; Van Pelt, Chad; Forster, Ryan E et al. (2013) CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73:2563-73
Martinez, Maria Elena; Jacobs, Elizabeth T; Baron, John A et al. (2012) Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst 104:732-9
Hibler, Elizabeth A; Hu, Chengcheng; Jurutka, Peter W et al. (2012) Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 21:368-75
Jacobs, Elizabeth T; Martinez, Maria Elena; Jurutka, Peter W (2011) Vitamin D: marker or mechanism of action? Cancer Epidemiol Biomarkers Prev 20:585-90